HOXA9 and glioblastoma: Moreover, high expression of WNT6 allowed the identification of a subgroup of HOXA9‐low GBM patients with a significantly shorter OS (median OS = 298 days) than those with low WNT6 levels (median OS = 447 days; log‐rank P = 0.013; Fig. S7).